Aimei Health Technology Files 8-K on Shareholder Votes
Ticker: AFJKR · Form: 8-K · Filed: Feb 4, 2025 · CIK: 1979005
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Aimei Health Tech (AMHT) is having a shareholder vote on Feb 4th - watch for updates.
AI Summary
Aimei Health Technology Co., Ltd. filed an 8-K on February 4, 2025, reporting on a submission of matters to a vote of security holders. The company, incorporated in the Cayman Islands with principal executive offices in New York, NY, is involved in the healthcare technology sector.
Why It Matters
This filing indicates important corporate actions are being put to a shareholder vote, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Aimei Health Technology Co., Ltd. (company) — Registrant
- 0001493152-25-004797 (filing_id) — Accession Number
- February 4, 2025 (date) — Date of Report
- Cayman Islands (jurisdiction) — State of incorporation
- New York, NY (location) — Principal Executive Offices
FAQ
What specific matters are being submitted to a vote of security holders?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals in this excerpt.
When was the report filed?
The report was filed on February 4, 2025.
What is the company's principal executive office location?
The principal executive offices are located at 10 East 53rd Street, Suite 3001, New York, NY 10022.
In which jurisdiction is Aimei Health Technology Co., Ltd. incorporated?
The company is incorporated in the Cayman Islands.
What is the Commission File Number for this filing?
The Commission File Number is 001-41880.
Filing Stats: 662 words · 3 min read · ~2 pages · Grade level 12.8 · Accepted 2025-02-04 10:58:26
Key Financial Figures
- $0.0001 — registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 44KB
- 0001493152-25-004797.txt ( ) — 262KB
- afjk-20250204.xsd (EX-101.SCH) — 4KB
- afjk-20250204_def.xml (EX-101.DEF) — 26KB
- afjk-20250204_lab.xml (EX-101.LAB) — 37KB
- afjk-20250204_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 7KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 4, 2025 Aimei Health Technology Co., Ltd By: /s/ Junheng Xie Name: Junheng Xie Title: Chief Executive Officer